Actively Recruiting
MOMENTOUS Study Evaluating AI ECG Device for Diagnosing Pulmonary Hypertension in Interstitial Lung Disease Patients
Led by Tempus AI · Updated on 2026-11-03
900
Participants Needed
41
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of an ECG-based artificial intelligence device to help predict if people with interstitial lung disease ILD are at high risk for undiagnosed pulmonary hypertension PH. The study aims to see whether using this device increases the number of new PH diagnoses over six months compared to standard care. This multi-center randomized trial focuses on adults diagnosed with ILD and assesses how well the AI device performs in clinical practice. Participants with ILD will each receive a 12-lead electrocardiogram ECG that the AI device analyzes to identify those at high risk for PH. Participants will be randomly assigned to either receive the device results or not. Those in the device group identified as high risk will undergo additional tests including an echocardiogram and right heart catheterization RHC. Other participants will continue with their usual care, which may include those tests if their doctor recommends them. During the study, participants will be followed for approximately six months to monitor new diagnoses of pulmonary hypertension. The research team will review how many participants receive new PH diagnoses in the different groups. Standard clinical care will continue throughout, and participants will have relevant heart and lung assessments as needed. The study will help determine if the AI device improves detection of pulmonary hypertension in people with ILD.
CONDITIONS
Brief Title
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Research Team
M
Momentous Study
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here